IRIS
STEFANI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 61.193
AS - Asia 17.234
EU - Europa 6.788
SA - Sud America 1.231
Continente sconosciuto - Info sul continente non disponibili 1.173
AF - Africa 124
OC - Oceania 16
Totale 87.759
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 60.834
SG - Singapore 13.168
CN - Cina 1.374
IT - Italia 1.364
BR - Brasile 1.028
IE - Irlanda 971
RU - Federazione Russa 947
HK - Hong Kong 844
UA - Ucraina 826
DE - Germania 683
VN - Vietnam 606
FR - Francia 577
BD - Bangladesh 396
GB - Regno Unito 350
SE - Svezia 299
JP - Giappone 227
FI - Finlandia 203
CA - Canada 186
PL - Polonia 171
KR - Corea 151
NL - Olanda 137
IN - India 112
AR - Argentina 78
MX - Messico 72
ID - Indonesia 70
AT - Austria 49
ZA - Sudafrica 45
IQ - Iraq 44
ES - Italia 43
TR - Turchia 37
EC - Ecuador 29
CO - Colombia 28
BE - Belgio 27
PK - Pakistan 26
UZ - Uzbekistan 24
EU - Europa 23
JM - Giamaica 23
VE - Venezuela 21
CZ - Repubblica Ceca 19
CL - Cile 17
MA - Marocco 17
MY - Malesia 17
SA - Arabia Saudita 16
PY - Paraguay 15
AU - Australia 14
CH - Svizzera 14
EG - Egitto 14
KG - Kirghizistan 14
CR - Costa Rica 13
PH - Filippine 13
RO - Romania 13
AE - Emirati Arabi Uniti 12
IL - Israele 12
KE - Kenya 12
LT - Lituania 11
TT - Trinidad e Tobago 11
AL - Albania 10
TW - Taiwan 10
BG - Bulgaria 9
GR - Grecia 9
RS - Serbia 9
NP - Nepal 8
PE - Perù 8
TN - Tunisia 8
AZ - Azerbaigian 7
DK - Danimarca 7
HN - Honduras 7
NI - Nicaragua 7
SK - Slovacchia (Repubblica Slovacca) 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
GE - Georgia 6
HR - Croazia 6
IR - Iran 6
JO - Giordania 6
PT - Portogallo 6
TH - Thailandia 6
DZ - Algeria 5
LB - Libano 5
GT - Guatemala 4
KZ - Kazakistan 4
NG - Nigeria 4
PR - Porto Rico 4
SV - El Salvador 4
AO - Angola 3
BB - Barbados 3
BY - Bielorussia 3
DM - Dominica 3
ET - Etiopia 3
GD - Grenada 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
PA - Panama 3
PS - Palestinian Territory 3
SC - Seychelles 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
BZ - Belize 2
EE - Estonia 2
Totale 86.574
Salva come PNG Salva come JPEG
Città #
Wilmington 15.478
Houston 14.771
Woodbridge 13.791
Fairfield 2.190
Singapore 2.025
Ashburn 1.415
San Jose 1.103
Ann Arbor 1.097
Seattle 845
Hong Kong 834
Jacksonville 749
Cambridge 743
Chandler 713
Dublin 650
Beijing 536
Medford 493
Council Bluffs 473
Dearborn 409
Santa Clara 363
Rome 344
The Dalles 299
New York 297
Los Angeles 265
Lawrence 229
Tokyo 202
Lauterbourg 187
Hanoi 166
Buffalo 163
Ho Chi Minh City 162
Moscow 137
San Diego 116
Milan 114
Kraków 110
Menlo Park 109
Munich 102
São Paulo 99
London 90
Dallas 87
North Bergen 79
Chicago 67
Helsinki 67
Brooklyn 62
Redondo Beach 58
Phoenix 53
Atlanta 52
Toronto 50
Mülheim 48
Warsaw 47
Montreal 46
Amsterdam 45
Norwalk 44
Orem 44
Nuremberg 43
Shanghai 42
Jakarta 40
Redwood City 39
Zhengzhou 37
Stockholm 35
Chennai 34
Johannesburg 32
Rio de Janeiro 32
Denver 31
Verona 31
Boardman 30
Boston 30
Hefei 30
Monte Vista 30
Naples 29
Da Nang 28
Mexico City 28
Seoul 28
Belo Horizonte 26
Durham 26
St Louis 26
Brussels 25
Manchester 25
Palo Alto 25
Philadelphia 25
Kunming 24
Salt Lake City 22
Detroit 21
Falls Church 21
Haiphong 21
Mountain View 21
Nanjing 21
Elk Grove Village 20
Miami 20
San Francisco 20
University Park 19
Columbus 18
Florence 18
Dhaka 17
Poplar 17
Tampa 17
Bologna 16
Frankfurt am Main 16
Guangzhou 16
Guarulhos 16
Ninh Bình 16
Salvador 16
Totale 63.938
Salva come PNG Salva come JPEG
Nome #
Strength and weaknesses of cerebrospinal fluid biomarkers in Alzheimer's disease and possible detection of overlaps with frailty process 639
Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia 621
The pharmacological blockade of medial forebrain bundle induces an acute pathological synchronization of the cortico-subthalamic nucleus-globus pallidus pathway. 617
The impact of rotigotine on cardiovascular autonomic function in early Parkinson's disease 614
Reasons driving treatment modification in Parkinson's disease: results from the cross-sectional phase of the REASON study. 609
Deep brain stimulation of CM/PF of thalamus could be the new elective target for tremor in advanced Parkinson's Disease? 606
Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease 603
Pathological gambling from dopamine agonist and deep brain stimulation of the nucleus tegmenti pedunculopontine 599
Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response. 597
Therapy for dyskinesias in Parkinson’s disease patients 597
Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT 592
Subdyskinetic apomorphine responses in globus pallidus and subthalamus of parkinsonian patients: lack of clear evidence for the 'indirect pathway' 576
Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients 573
Successful subthalamic stimulation, but levodopa-induced dystonia, in a genetic Parkinson's disease 570
Posterior cortical atrophy with unilateral occipito-temporal degeneration 564
Reduced GABA Content in the Motor Thalamus during effective deep brain stimulation of the subthalamic nucleus 560
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 553
Motor and non-motor effects of PPN-DBS in PD patients: insights from intra-operative electrophysiology 553
Re: Stereotactic microdialysis of the basal ganglia in Parkinson's disease 549
The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients 547
Effects of deep brain stimulation of the peduncolopontine area on working memory tasks in patients with Parkinson's disease 536
Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian-parafascicularis complex. 527
Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients 525
Neuroacanthocytosis associated with a defect of the 4.1R membrane protein 524
Spontaneous sleep modulates the firing pattern of Parkinsonian subthalamic nucleus 512
Intensity-dependent facial emotion recognition and cognitive functions in Parkinson's disease 508
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis. 508
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis 501
Clinical and genetic study of a large SPG4 Italian family 497
Do CSF levels of t-Tau, p-Tau and beta(1-42) amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A I-123-FP-CIT study in the early stages of the disease 497
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. 497
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease 495
Adherence to anti-Parkinson drug therapy in the "rEASON" sample of Italian patients with Parkinson's disease: The linguistic validation of the Italian version of the "morisky Medical Adherence scale-8 items" 495
CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia 494
Autonomic Function Tests and MIBG in Parkinson's Disease: Correlation to Disease Duration and Motor Symptoms 492
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus. 488
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain 487
Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment 487
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission 485
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease 483
Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration 483
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature 481
Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease 481
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease 476
Acute inactivation of the medial forebrain bundle imposes oscillations in the SNr: a challenge for the 6-OHDA model? 475
Selective vulnerability of pallidal neurons in the early phases of manganese intoxication 474
Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease 473
Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease 472
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids 468
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 467
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 465
Acute nigro-striatal blockade alters cortico-striatal encoding: An in vivo electrophysiological study 461
Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart 460
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 457
The early course of affective and cognitive symptoms in de novo patients with Parkinson's disease 457
Distinct roles of cortical and pallidal β and γ frequencies in hemiparkinsonian and dyskinetic rats 454
CSF biomarker variability in the Alzheimer's Association quality control program 453
Deep brain stimulation of pedunculopontine tegmental nucleus: role in sleep modulation in advanced Parkinson disease patients: one-year follow-up. 451
Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons 451
Subthalamic stimulation and levodopa modulate cortical reactivity in Parkinson's patients 449
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus 448
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease. 447
Neurotensin effects on N-type calcium currents among rat pallidal neurons: an electrophysiological and immunohistochemical study. 444
Bilateral GPi DBS is useful to reduce abnormal involuntary movements in advanced Parkinson's disease patients, but its action is related to modality and site of stimulation 443
Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer’s disease 443
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD 441
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 438
Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson disease 438
Deep brain stimulation of both subthalamic nucleus and internal globus pallidus restores intracortical inhibition in Parkinson's disease paralleling apomorphine effects: a paired magnetic stimulation study 437
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations 436
Pedunculopontine nucleus stimulation influences REM sleep in Parkinson's disease 435
Alexithymia is a non-motor symptom of Parkinson disease 433
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 432
Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in PD patients 431
Outward potassium currents activated by depolarization in rat globus pallidus 431
Vulnerability of medium spiny striatal neurons to glutamate: role of Na+/K+ ATPase 429
Association analysis between Alzheimer's disease and the Nicastrin gene polymorphisms 429
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids 427
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers 427
Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients 427
Thalamic ¹²³I FP-CIT uptake in a patient with clinical diagnosis of Parkinson's disease and depression 425
In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway. 424
Pramipexole in comparison to l-dopa: a neuropsychological study 421
Rotigotine effect on sleep in a de novo Parkinson's Disease patient affected by periodic limb movement disorder 419
Deep brain stimulation of the pedunculopontine tegmentum and subthalamic nucleus: effects on gait in Parkinson's disease 418
Theta Burst Stimulation Modulates Cerebellar-Cortical Connectivity in Patients with Progressive Supranuclear Palsy 416
Catecholamine-based treatment in AD patients: expectations and delusions 415
D2-mediated modulation of N-type calcium currents in rat globus pallidus neurons following dopamine denervation 414
CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment 413
Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: molecular imaging with ¹²³I-MIBG. 412
L-dopa modulates motor cortex excitability in Alzheimer's disease patients 408
The modulation of dopamine receptors in rat striatum 408
Basic research in substantia nigra and ventral tegmental area: clinical implications 408
Lamotrigine derivatives and riluzole inhibit INa,P in cortical neurons 406
The modulation of calcium currents by the activation of mGluRs. Functional implications 405
Hemodynamic changes in Alzheimer's disease: A leading role behind the courtain? Commentary on "CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease" by Lista et al 403
Deep brain stimulation in Parkinson's disease patients: biochemical evidence 402
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations.(Reply from the authors) 401
Psychiatric profile of motor subtypes of de novo drug-naïve Parkinson's disease patients 398
Cardiac rhabdomyosarcoma: a clinicopathologic and electron microscopy study 396
Totale 48.013
Salva come PNG Salva come JPEG
Categoria #
all - tutte 212.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 212.425
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.744 0 342 137 125 87 152 586 143 134 142 229 667
2022/20232.175 271 160 78 217 166 592 240 115 167 6 118 45
2023/2024855 90 33 63 18 85 143 36 144 22 53 14 154
2024/202515.405 171 1.254 584 330 113 471 464 357 642 527 6.024 4.468
2025/202611.194 814 382 1.173 924 887 350 1.325 1.466 1.228 1.181 907 557
2026/20271.473 941 532 0 0 0 0 0 0 0 0 0 0
Totale 87.759